Patient-centered dosing in metastatic breast cancer

For people living with metastatic breast cancer, treatment is lifelong. How dosing decisions are made — and how those choices are discussed — can have a profound impact on your patients’ daily lives, emotional well-being, and treatment adherence. Our panel shared practical strategies and real-world examples of how adjusting treatment cadence and dosing can preserve quality of life while maintaining clinical effectiveness. They also discussed new bilingual tools from LBBC in partnership with Sidney Kimmel Cancer Center that support shared decision-making and enhance patient education. About the speakers Amy Leader, DrPH, MPH Dr. Leader is a professor in the division of population science, department of medical oncology at Thomas Jefferson University. As an associate director for community outreach and engagement at the Sidney Kimmel Comprehensive Cancer Center at Jefferson, an NCI-designated cancer center, Dr. Leader leads research focused on health disparities, community engagement, and health communication across the cancer continuum. Julia Maués Julia is a patient advocate and cofounder of GRASP. Julia leads the Patient-Centered Dosing Initiative (PCDI), which advocates for treatment strategies that optimize both efficacy and tolerability to improve patient outcomes. Learn more about patient-centered dosing: https://www.lbbc.org/about-breast-cancer/types-breast-cancer/metastatic-breast-cancer/side-effects/patient-centered-dosing Learn more about the Patient-Centered Dosing Initiative: https://www.therightdose.org/ At Living Beyond Breast Cancer, we make sure people facing breast cancer have the support they need. We’re here with real answers, real stories, and real help—every step of the way. Follow us: Facebook: https://www.facebook.com/livingbeyondbreastcancer LinkedIn: https://www.linkedin.com/company/living-beyond-breast-cancer Instagram: https://instagram.com/livingbeyondbc YouTube: https://youtube.com/user/LBBC1991